Skip to main content
TipRanks
Go Ultimate75% OFF

Lantern Pharma (LTRN) Ratios

343 Followers

Lantern Pharma Ratios

LTRN's free cash flow for Q3 2026 was $-3.34M. For the 2026 fiscal year, LTRN's free cash flow was increased by $3.00 and operating cash flow was $-3.34M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio2.405.8316.1820.9931.26
Quick Ratio2.405.8316.1820.9931.26
Cash Ratio0.981.738.1913.2922.15
Solvency Ratio-3.80-4.74-5.76-5.09-5.19
Operating Cash Flow Ratio-3.48-4.11-5.36-4.56-4.55
Short-Term Operating Cash Flow Coverage-0.200.000.000.00-69.65
Net Current Asset Value$ 6.30M$ 20.86M$ 40.60M$ 55.92M$ 70.34M
Leverage Ratios
Debt-to-Assets Ratio7.120.010.010.000.00
Debt-to-Equity Ratio12.020.010.010.000.00
Debt-to-Capital Ratio0.920.010.010.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.691.211.071.051.03
Debt Service Coverage Ratio-0.220.000.00-70.58-82.76
Interest Coverage Ratio0.000.000.00-70.630.00
Debt to Market Cap2.380.000.000.000.00
Interest Debt Per Share7.210.020.020.020.02
Net Debt to EBITDA-4.330.351.372.584.08
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT95.22%93.54%89.28%98.80%98.19%
Return on Assets (ROA)-155.13%-81.27%-36.57%-24.24%-16.72%
Return on Equity (ROE)-262.00%-98.08%-39.02%-25.45%-17.27%
Return on Capital Employed (ROCE)-275.14%-104.59%-43.64%-25.76%-17.58%
Return on Invested Capital (ROIC)-21.13%-103.66%-43.45%-25.73%-17.54%
Return on Tangible Assets-155.13%-81.27%-36.57%-24.24%-16.72%
Earnings Yield-51.84%-60.53%-34.40%-21.76%-14.21%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.000.000.190.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle0.000.00-1966.950.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.000.001966.950.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.44-1.66-1.32-1.18-0.97
Free Cash Flow Per Share-1.44-1.66-1.32-1.18-0.97
Dividend Paid and CapEx Coverage Ratio-9141.10-1413.86-765.80-458.54-683.37
Capital Expenditure Coverage Ratio-9141.10-1413.86-765.80-458.54-683.37
Operating Cash Flow Coverage Ratio-0.20-73.11-61.19-241.40-51.68
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-47.48%-51.92%-30.96%-19.52%-12.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.93-0.00-2.91-4.60-7.04
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio5.051.621.131.171.22
Price-to-Free Cash Flow (P/FCF) Ratio-2.11-1.93-3.23-5.12-8.20
Price-to-Operating Cash Flow Ratio-2.11-1.93-3.23-5.13-8.22
Price-to-Earnings Growth (PEG) Ratio0.02-0.00-0.24-0.29-0.37
Enterprise Value Multiple-6.26-1.30-1.56-1.97-2.84
Enterprise Value107.14M27.06M24.70M28.39M35.70M
EV to EBITDA-6.26-1.30-1.56-1.97-2.84
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-6.83-1.52-1.72-2.22-3.37
EV to Operating Cash Flow-6.83-1.52-1.72-2.22-3.37
Tangible Book Value Per Share0.601.973.775.166.56
Shareholders’ Equity Per Share0.601.973.775.166.56
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-1.57-1.93-1.47-1.31-1.13
Tax Burden1.001.001.001.001.00
Interest Burden1.001.001.000.990.98
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.920.860.900.900.86

Currency in USD